For example, as mentioned above, DRAK2 affects NAFLD, and one study suggested that it may be involved in the development of NAFLD by affecting the splicing mechanism of RNA (Li et al., 2021). This evidence concerns the gene STK17B and metabolic dysfunction-associated steatotic liver disease.